Cochlear (ASX:COH) - Stock Price, News & Analysis

COH Stock Overview

Cochlear Limited provides implantable hearing solutions for children and adults worldwide.

COH fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	3/6
Financial Health	6/6
Dividends	0/6

Rewards

Earnings are forecast to grow 12.33% per year

Earnings grew by 4% over the past year

Risk Analysis

COH passed our risk checks.

Cochlear Limited Competitors

Sonic Healthcare

ASX:SHL

AU$13.7b

Ramsay Health Care

ASX:RHC

AU$11.2b

Pro Medicus

ASX:PME

AU$9.1b

Austco Healthcare

ASX:AHC

AU$57.5m

Price History & Performance

Summary of all time highs, changes and price drops for Cochlear
Historical stock prices
Current Share Price	AU$261.26
52 Week High	AU$274.65
52 Week Low	AU$197.74
Beta	0.39
1 Month Change	7.73%
3 Month Change	-4.39%
1 Year Change	23.57%
3 Year Change	16.29%
5 Year Change	53.72%
Change since IPO	8,756.27%

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Oct 04

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Sep 12

Recent updates

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Oct 04

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Oct 11

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Aug 23

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Jul 16

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

May 19

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Apr 09

Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)

Feb 04

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Dec 24

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Oct 30

This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders

Oct 12

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Oct 06

Returns On Capital Signal Tricky Times Ahead For Cochlear (ASX:COH)

Aug 16

Cochlear (ASX:COH) Has A Pretty Healthy Balance Sheet

Jun 24

A Look At The Intrinsic Value Of Cochlear Limited (ASX:COH)

May 17

There Are Reasons To Feel Uneasy About Cochlear's (ASX:COH) Returns On Capital

Apr 29

These 4 Measures Indicate That Cochlear (ASX:COH) Is Using Debt Reasonably Well

Mar 20

Insider Buying: The Cochlear Limited (ASX:COH) Independent Non-Executive Director Just Bought 24% More Shares

Mar 02

Cochlear Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 20

Calculating The Intrinsic Value Of Cochlear Limited (ASX:COH)

Feb 11

Our Take On The Returns On Capital At Cochlear (ASX:COH)

Jan 25

Do Institutions Own Cochlear Limited (ASX:COH) Shares?

Jan 07

Introducing Cochlear (ASX:COH), The Stock That Zoomed 107% In The Last Five Years

Dec 21

How Much Is Cochlear Limited (ASX:COH) CEO Getting Paid?

Dec 06

Does Cochlear (ASX:COH) Have A Healthy Balance Sheet?

Nov 18

Shareholder Returns

	COH	AU Medical Equipment	AU Market
7D	0.2%	-1.1%	-1.1%
1Y	23.6%	7.0%	-3.6%

Return vs Industry: COH exceeded the Australian Medical Equipment industry which returned 7% over the past year.

Return vs Market: COH exceeded the Australian Market which returned -3.6% over the past year.

Price Volatility

Is COH's price volatile compared to industry and market?
COH volatility
COH Average Weekly Movement	1.9%
Medical Equipment Industry Average Movement	10.0%
Market Average Movement	8.9%
10% most volatile stocks in AU Market	17.6%
10% least volatile stocks in AU Market	3.1%

Stable Share Price: COH is less volatile than 75% of Australian stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: COH's weekly volatility (2%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
1981	4,800	Dig Howitt	https://www.cochlear.com

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Cochlear Limited Fundamentals Summary

How do Cochlear's earnings and revenue compare to its market cap?
COH fundamental statistics
Market Cap	AU$16.94b
Earnings (TTM)	AU$300.60m
Revenue (TTM)	AU$1.94b

56.9x

P/E Ratio

8.8x

P/S Ratio

Is COH overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
COH income statement (TTM)
Revenue	AU$1.94b
Cost of Revenue	AU$488.00m
Gross Profit	AU$1.45b
Other Expenses	AU$1.15b
Earnings	AU$300.60m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Feb 16, 2024

Earnings per share (EPS)	4.59
Gross Margin	74.79%
Net Profit Margin	15.53%
Debt/Equity Ratio	0%

How did COH perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

72%

Payout Ratio

COH Stock Overview

Rewards

Risk Analysis

Cochlear Limited Competitors

ASX:SHL

AU$13.7b

ASX:RHC

AU$11.2b

ASX:PME

AU$9.1b

ASX:AHC

AU$57.5m

Price History & Performance

Recent News & Updates

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Upcoming dividend of AU$1.75 per share at 1.2% yield

Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T

Cochlear Limited to Report Fiscal Year 2024 Results on Aug 15, 2024

Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat

Recent updates

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Upcoming dividend of AU$1.75 per share at 1.2% yield

Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T

Cochlear Limited to Report Fiscal Year 2024 Results on Aug 15, 2024

Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Upcoming dividend of AU$1.55 per share at 1.3% yield

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear Limited Provides Earnings Outlook for the Year 2023

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Is Cochlear (ASX:COH) A Risky Investment?

Cochlear Limited, Annual General Meeting, Oct 17, 2023

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

FDA Approves Cochlear Limited's Nucleus 8 Sound Processor, Smaller, Smarter, Better Connected Cochlear Implant Technology

Key Executive recently bought AU$97k worth of stock

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Upcoming dividend of AU$1.45 per share

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Full year 2022 earnings: EPS misses analyst expectations

Cochlear Announces Final Dividend Payable on 17 October 2022

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Cochlear Limited Appoints Karen Penrose to Board, Effective on 1 July 2022

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Cochlear Limited, Annual General Meeting, Oct 18, 2022

Cochlear Limited to Report First Half, 2023 Results on Feb 15, 2023

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Upcoming dividend of AU$1.55 per share

Investor sentiment improved over the past week

First half 2022 earnings: EPS and revenues exceed analyst expectations

Cochlear Limited Announces Interim Dividend Expected to Be Payable on 21 April 2022

Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)

FDA Approves Cochlear Nucleus Implants for Unilateral Hearing Loss/Single-Sided Deafness

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Independent Non-Executive Director recently bought AU$56k worth of stock

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Cochlear Limited Advises of US Patent Infringement Complaint

Upcoming dividend of AU$1.40 per share

CEO, MD exercised options and sold AU$295k worth of stock

Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing Preservation in Combination with Cochlear Implantation

Independent Non-Executive Director recently bought AU$94k worth of stock

Independent Chairman Roderic Holliday-Smith has left the company

Independent Chairman Roderic Holliday-Smith has left the company

Full year 2021 earnings released: EPS AU$4.97 (vs AU$4.00 loss in FY 2020)

Cochlear Limited Provides Earnings Guidance for the Fiscal Year 2022

Returns On Capital Signal Tricky Times Ahead For Cochlear (ASX:COH)

Non-Executive Independent Director Abbas Hussain has left the company

Cochlear (ASX:COH) Has A Pretty Healthy Balance Sheet

A Look At The Intrinsic Value Of Cochlear Limited (ASX:COH)

New Cochlear CoPilot app to help adults improve hearing outcomes through skills training

There Are Reasons To Feel Uneasy About Cochlear's (ASX:COH) Returns On Capital

These 4 Measures Indicate That Cochlear (ASX:COH) Is Using Debt Reasonably Well

Upcoming Dividend of AU$1.15 Per Share